Higher-than-usual doses of radiation in the treatment of inoperable lung cancer can be safely combined with immunotherapy without increasing the risk of severe lung inflammation (pneumonitis). This is the key finding of a recent study conducted by Karl Landsteiner University of Health Sciences (KL Krems).
High-dose radiotherapy can be safe and promising for lung cancer in combination with immunotherapy
